Crescent Grove Advisors’s Profound Medical PROF Stock Holding History

Crescent Grove Advisors’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$348K	Buy	+60,038	New	+$408K	0.03%	238

Other funds holding PROF

Ring Mountain Capital Tiburon, California $245M AUM 48.62% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return

Crescent Grove Advisors's PROF Position: Q3 2026 in Review

Crescent Grove Advisors opened a new position in Profound Medical (PROF) in Q3 2026: 60,038 shares worth $348K. The stake represents 0.03% of the portfolio and ranks #238 among its holdings.

5 funds tracked by Wall St. Rank hold PROF as of Q3 2026.

Crescent Grove Advisors held 60,038 shares of Profound Medical worth $348K as of Q3 2026.
Profound Medical was a new Crescent Grove Advisors position in Q3 2026.
Profound Medical made up 0.03% of Crescent Grove Advisors's portfolio in Q3 2026, its #238 holding.
5 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.

Based on Crescent Grove Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.